Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)Ended earlyNCT01382745What this trial is testingNimotuzumab With Radiotherapy in the Treatment of Anal Canal CancersWho this might be right forSquamous Cell Carcinoma of Anal Canal Dr. Te Vuong 1
Testing effectiveness (Phase 2)Study completedNCT05060471What this trial is testingPD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced SCCA PatientsWho this might be right forAnal Canal CancerAnal Squamous Cell CarcinomaAnal Cancer+3 more Sun Yat-sen University 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06304545What this trial is testingTreatment of Rectal Cancer With Long-term Concurrent Chemoradiotherapy Combined With CamrelizumabWho this might be right forRectal Cancer Harbin Medical University 48
Not applicableLooking for participantsNCT04907643What this trial is testingVirtual Reality for GI Cancer Pain to Improve Patient Reported OutcomesWho this might be right forCancer PainVisceral PainGastrointestinal Neoplasms+76 more Cedars-Sinai Medical Center 360
Not applicableStudy completedNCT00059891What this trial is testingAnal Sphincter Prosthesis in Treating Patients Who Are Undergoing Surgery for Anal or Rectal CancerWho this might be right forAnal CancerColorectal CancerPerioperative/Postoperative Complications Memorial Sloan Kettering Cancer Center 4
Early research (Phase 1)Study completedNCT00019110What this trial is testingVaccine Therapy in Treating Patients With Advanced or Recurrent CancerWho this might be right forAnal CancerCervical CancerEsophageal Cancer+3 more National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT00025090What this trial is testingRadiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal CancerWho this might be right forAnal Cancer University College London (UCL) Cancer Institute 600
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT04719988What this trial is testingAnti-PD-1 and mDCF Followed by Chemoradiotherapy in Patients With Stage III Squamous Cell Anal Carcinoma.Who this might be right forSquamous Cell Carcinoma of the Anus Stage III Centre Hospitalier Universitaire de Besancon 55
Large-scale testing (Phase 3)Study completedNCT00003652What this trial is testingCombination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal CancerWho this might be right forAnal Cancer UNICANCER 350
Testing effectiveness (Phase 2)Looking for participantsNCT06493019What this trial is testingStudy of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal CancerWho this might be right forAnal Cancer Dustin Deming 23
Early research (Phase 1)Study completedNCT00031681What this trial is testing7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)Who this might be right forAdvanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more National Cancer Institute (NCI) 41
Post-approval studies (Phase 4)UnknownNCT00274885What this trial is testingRelationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal CancerWho this might be right forCancer GERCOR - Multidisciplinary Oncology Cooperative Group 58
Not applicableStudy completedNCT01836926What this trial is testingTaTME Versus Open Intersphincteric Resection After Neoadjuvant Concurrent Chemoradiotherapy.Who this might be right forRectal Cancer Osama Mohammad Ali ElDamshety 110
Testing effectiveness (Phase 2)Study completedNCT00316888What this trial is testingCetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal CancerWho this might be right forAnal Cancer ECOG-ACRIN Cancer Research Group 63
Testing effectiveness (Phase 2)WithdrawnNCT04499352What this trial is testingTest BI 754091 Alone or in Combination With BI 836880 in People Who Have Advanced Anal CancerWho this might be right forAnal Canal Squamous Cell Carcinoma Boehringer Ingelheim
Testing effectiveness (Phase 2)Active Not RecruitingNCT04929028What this trial is testingTherapy Adapted for High Risk and Low Risk HIV-Associated Anal CancerWho this might be right forAIDS-Related Anal CarcinomaAnal Margin Squamous Cell CarcinomaAnal Non-Keratinizing Squamous Cell Carcinoma+7 more National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT02865135What this trial is testingTrial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal CancerWho this might be right forCancer of Head and NeckCancer of CervixCancer of Anus Dana-Farber Cancer Institute 11
Testing effectiveness (Phase 2)Ended earlyNCT04066894What this trial is testingSacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE StudyWho this might be right forLow Anterior Resection SyndromeMalignant Anal NeoplasmMalignant Bladder Neoplasm+8 more M.D. Anderson Cancer Center 3